zelquistinel
Phase 2- Indications
- Major depressive disorder
Company intelligence / Profile preview
Gate Neurosciences
Indianapolis, Indiana, United Statesgateneuro.com ↗
- Ownership
- Private
- Employees
- ~12
- Development stage
- Phase 2
01
Overview
Gate Neurosciences has advanced its lead candidate, zelquistinel—a once-weekly oral medicine targeting synaptic function—into Phase 2 trials for depression. The therapy aims to provide rapid symptom relief compared to traditional antidepressants. The company leverages a precision medicine approach using objective biomarkers and advanced analytics to optimize patient selection and outcomes. Additional pipeline details are limited but include other differentiated mechanisms for neuropsychiatric and cognitive disorders.
- Therapeutic areas
- PsychiatryNeurology
- Modalities
- Small molecules (e.g., zelquistinel)Precision neuroscience tools/biomarker-driven approaches
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
Beacon Biosignals – partnership for biomarker capture using DREEM device in clinical studies.Catalio Capital – investor with board representation post-acquisition of Boost.
Beyond the preview
Go deeper on Gate Neurosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Gate Neurosciences.